Cargando…

HMCDA: a novel method based on the heterogeneous graph neural network and metapath for circRNA-disease associations prediction

Circular RNA (CircRNA) is a type of non-coding RNAs in which both ends are covalently linked. Researchers have demonstrated that many circRNAs can act as biomarkers of diseases. However, traditional experimental methods for circRNA-disease associations identification are labor-intensive. In this wor...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Shiyang, Liu, Siwei, Song, Junliang, Lin, Qiang, Zhao, Shihong, Li, Shuaixin, Li, Jiahui, Liang, Shangsong, Wang, Jingjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494331/
https://www.ncbi.nlm.nih.gov/pubmed/37697297
http://dx.doi.org/10.1186/s12859-023-05441-7
Descripción
Sumario:Circular RNA (CircRNA) is a type of non-coding RNAs in which both ends are covalently linked. Researchers have demonstrated that many circRNAs can act as biomarkers of diseases. However, traditional experimental methods for circRNA-disease associations identification are labor-intensive. In this work, we propose a novel method based on the heterogeneous graph neural network and metapaths for circRNA-disease associations prediction termed as HMCDA. First, a heterogeneous graph consisting of circRNA-disease associations, circRNA-miRNA associations, miRNA-disease associations and disease-disease associations are constructed. Then, six metapaths are defined and generated according to the biomedical pathways. Afterwards, the entity content transformation, intra-metapath and inter-metapath aggregation are implemented to learn the embeddings of circRNA and disease entities. Finally, the learned embeddings are used to predict novel circRNA-disase associations. In particular, the result of extensive experiments demonstrates that HMCDA outperforms four state-of-the-art models in fivefold cross validation. In addition, our case study indicates that HMCDA has the ability to identify novel circRNA-disease associations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-023-05441-7.